Unique clinical presentations and follow-up outcomes from experience with congenital disorders of glycosylation: PMM2-PGM1-DPAGT1-MPI-POMT2-B3GALNT2-DPM1-SRD5A3-CDG

被引:1
作者
Celik, Merve Yoldas [1 ]
Yazici, Havva [2 ]
Erdem, Fehime [2 ]
Yanbolu, Ayse Yuksel [2 ]
Aykut, Ayca [3 ]
Durmaz, Asude [3 ]
Zeybek, Selcan [4 ]
Canda, Ebru [2 ]
Ucar, Sema Kalkan [2 ]
Coker, Mahmut [2 ]
机构
[1] Ege Univ, Fac Med, Dept Pediat Metab, TR-35040 Izmir, Turkiye
[2] Ege Univ, Dept Pediat, Div Pediat Metab & Nutr, Fac Med, Izmir, Turkiye
[3] Ege Univ, Dept Genet, Fac Med, Izmir, Turkiye
[4] Tinaztepe Univ, Fac Med, Dept Genet, Izmir, Turkiye
关键词
B3GALNT2; CDG; DPAGT1; DPM1; POMT2; SRD5A3; O-GLYCOSYLATION; MUTATIONS; DIAGNOSIS; HYPOGLYCOSYLATION; MANAGEMENT; SRD5A3-CDG; PATIENT; PROTEIN; CDG;
D O I
10.1515/jpem-2022-0641
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Congenital Glycosylation Disorders (CDG) are a large group of inherited metabolic diseases with multi-organ involvement. Herein, we aimed to expand the clinical characteristics of patients with CDG based on our experience with diagnoses and follow-up of CDG patients from different subtypes.Methods: The clinical and laboratory findings from the last 15 years were reviewed retrospectively in Ege University Child Metabolism and Nutrition Department.Results: There were 8 (57.2 %) females and 6 (42.8 %) males. Diagnoses of the patients were PMM2-CDG (n=4), PGM1-CDG (n=2), DPAGT1-CDG (n=2), SRD5A3-CDG (n=2), MPI-CDG (n=1), POMT2-CDG (n=1), B3GALNT2-CDG (n=1), DPM1-CDG (n=1). The clinical findings of the patients were dysmorphia (85.7 %), developmental delay (85.7 %), intellectual disability (85.7 %), ocular abnormalities (64.2 %), skeletal malformations (64.2 %), failure to thrive (57.1 %), microcephaly (57.1 %), hepatomegaly (35.7 %), hearing loss (35.7 %), seizures (28.5 %), gastrointestinal symptoms (21.4 %), endocrine abnormalities (21.4 %), and cardiac abnormalities (7.1 %). Laboratory findings were abnormal TIEF (92.8 %), abnormal liver enzymes (64.2 %), decreased protein C (64.2 %), decreased antithrombin III (64.2 %), decreased protein S (42.8 %), hypogammaglobulinemia (35.7 %), cerebellar hypoplasia (28.5 %), CK elevation (7.1 %), and hypoglycemia (7.1 %).Conclusions: This study contributes to the literature by sharing our ultra-rare DPM1-CDG case with less than 20 cases in the literature and expanding the clinical and molecular characteristics of other CDG patients. Hyperinsulinemic hypoglycemia, short stature, hypothyroidism, growth hormone deficiency, hypogammaglobulinemia, pericardial effusion, elevated CK, congenital myasthenia, and anorectal malformation were unique findings that were observed. Cerebello-ocular findings accompanying multi-organ involvement were an essential clue for a possible CDG.
引用
收藏
页码:530 / 538
页数:9
相关论文
共 43 条
[1]   International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG): Diagnosis, follow-up, and management [J].
Altassan, Ruqaiah ;
Radenkovic, Silvia ;
Edmondson, Andrew C. ;
Barone, Rita ;
Brasil, Sandra ;
Cechova, Anna ;
Coman, David ;
Donoghue, Sarah ;
Falkenstein, Kristina ;
Ferreira, Vanessa ;
Ferreira, Carlos ;
Fiumara, Agata ;
Francisco, Rita ;
Freeze, Hudson ;
Grunewald, Stephanie ;
Honzik, Tomas ;
Jaeken, Jaak ;
Krasnewich, Donna ;
Lam, Christina ;
Lee, Joy ;
Lefeber, Dirk ;
Marques-da-Silva, Dorinda ;
Pascoal, Carlota ;
Quelhas, Dulce ;
Raymond, Kimiyo M. ;
Rymen, Daisy ;
Seroczynska, Malgorzata ;
Serrano, Mercedes ;
Sykut-Cegielska, Jolanta ;
Thiel, Christian ;
Tort, Frederic ;
Vals, Mari-Anne ;
Videira, Paula ;
Voermans, Nicol ;
Witters, Peter ;
Morava, Eva .
JOURNAL OF INHERITED METABOLIC DISEASE, 2021, 44 (01) :148-163
[2]   International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up [J].
Altassan, Ruqaiah ;
Peanne, Romain ;
Jaeken, Jaak ;
Barone, Rita ;
Bidet, Muad ;
Borgel, Delphine ;
Brasil, Sandra ;
Cassiman, David ;
Cechova, Anna ;
Coman, David ;
Corral, Javier ;
Correia, Joana ;
de la Morena-Barrio, Maria Eugenia ;
de Lonlay, Pascale ;
Dos Reis, Vanessa ;
Ferreira, Carlos R. ;
Fiumara, Agata ;
Francisco, Rita ;
Freeze, Hudson ;
Funke, Simone ;
Gardeitchik, Thatjana ;
Gert, Matthijs ;
Girad, Muriel ;
Giros, Marisa ;
Gruenewald, Stephanie ;
Hernandez-Caselles, Trinidad ;
Honzik, Tomas ;
Hutter, Marlen ;
Krasnewich, Donna ;
Lam, Christina ;
Lee, Joy ;
Lefeber, Dirk ;
Marques-de-Silva, Dorinda ;
Martinez, Antonio F. ;
Moravej, Hossein ;
Ounap, Katrin ;
Pascoal, Carlota ;
Pascreau, Tiffany ;
Patterson, Marc ;
Quelhas, Dulce ;
Raymond, Kimiyo ;
Sarkhail, Peymaneh ;
Schiff, Manuel ;
Seroczynska, Malgorzata ;
Serrano, Mercedes ;
Seta, Nathalie ;
Sykut-Cegielska, Jolanta ;
Thiel, Christian ;
Tort, Federic ;
Vals, Mari-Anne .
JOURNAL OF INHERITED METABOLIC DISEASE, 2019, 42 (01) :5-28
[3]   Clinical, biochemical and molecular phenotype of congenital disorders of glycosylation: long-term follow-up [J].
Bogdanska, Anna ;
Lipinski, Patryk ;
Szymanska-Rozek, Paulina ;
Jezela-Stanek, Aleksandra ;
Rokicki, Dariusz ;
Socha, Piotr ;
Tylki-Szymanska, Anna .
ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
[4]   CDG Therapies: From Bench to Bedside [J].
Brasil, Sandra ;
Pascoal, Carlota ;
Francisco, Rita ;
Marques-da-Silva, Dorinda ;
Andreotti, Giuseppina ;
Videira, Paula A. ;
Morava, Eva ;
Jaeken, Jaak ;
Ferreira, Vanessa dos Reis .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (05)
[5]  
Bursle C, 2017, JIMD REPORTS, VOL 34, P27, DOI 10.1007/8904_2016_7
[6]   Consensus guideline for the diagnosis and management of mannose phosphate isomerase-congenital disorder of glycosylation [J].
Cechova, Anna ;
Altassan, Ruqaiah ;
Borgel, Delphine ;
Bruneel, Arnaud ;
Correia, Joana ;
Girard, Muriel ;
Harroche, Annie ;
Kiec-Wilk, Beata ;
Mohnike, Klaus ;
Pascreau, Tiffany ;
Pawlinski, Lukasz ;
Radenkovic, Silvia ;
Vuillaumier-Barrot, Sandrine ;
Aldamiz-Echevarria, Luis ;
Couce, Maria Luz ;
Martins, Esmeralda G. ;
Quelhas, Dulce ;
Morava, Eva ;
de Lonlay, Pascale ;
Witters, Peter ;
Honzik, Tomas .
JOURNAL OF INHERITED METABOLIC DISEASE, 2020, 43 (04) :671-693
[7]   Phenotype and Genotype Study of Chinese POMT2-Related α-Dystroglycanopathy [J].
Chen, Xiao-Yu ;
Song, Dan-Yu ;
Jiang, Li ;
Tan, Dan-Dan ;
Liu, Yi-Dan ;
Liu, Jie-Yu ;
Chang, Xing-Zhi ;
Xing, Guo-Gang ;
Toda, Tatsushi ;
Xiong, Hui .
FRONTIERS IN GENETICS, 2021, 12
[8]   Expanding the Phenotype of B3GALNT2-Related Disorders [J].
D'haenens, Erika ;
Vergult, Sarah ;
Menten, Bjorn ;
Dheedene, Annelies ;
Kooy, R. Frank ;
Callewaert, Bert .
GENES, 2022, 13 (04)
[9]   Keeping an eye on congenital disorders of O-glycosylation: A systematic literature review [J].
Francisco, Rita ;
Pascoal, Carlota ;
Marques-da-Silva, Dorinda ;
Morava, Eva ;
Gole, Glen A. ;
Coman, David ;
Jaeken, Jaak ;
dos Reis Ferreira, Vanessa .
JOURNAL OF INHERITED METABOLIC DISEASE, 2019, 42 (01) :29-48
[10]   New and potential strategies for the treatment of PMM2-CDG [J].
Gamez, Alejandra ;
Serrano, Mercedes ;
Gallego, Diana ;
Vilas, Alicia ;
Perez, Belen .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2020, 1864 (11)